SNCA c.116A>G ;(p.Y39C)

Variant ID: 4-90756703-T-C

NM_000345.3(SNCA):c.116A>G;(p.Y39C)

This variant was identified in 9 publications

View GRCh38 version.




Publications:


Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies.

Frontiers In Neurology
Menon, Sindhu S; Armstrong, Sabrina S; Hamzeh, Amir A; Visanji, Naomi P NP; Sardi, Sergio Pablo SP; Tandon, Anurag A
Publication Date: 2022

Variant appearance in text: SNCA: Y39C
PubMed Link: 35614915
Variant Present in the following documents:
  • Main text
  • fneur-13-852003.pdf
View BVdb publication page



Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue.

Pharmaceuticals (Basel, Switzerland)
Janowski, Marcin M; Milewska, Małgorzata M; Zare, Peyman P; Pękowska, Aleksandra A
Publication Date: 2021-08-04

Variant appearance in text: SNCA: Y39C
PubMed Link: 34451862
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-14-00765.pdf
View BVdb publication page



Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Translational Neurodegeneration
Maiti, Panchanan P; Manna, Jayeeta J; Dunbar, Gary L GL
Publication Date: 2017

Variant appearance in text: SNCA: Y39C
PubMed Link: 29090092
Variant Present in the following documents:
  • Main text
  • 40035_2017_Article_99.pdf
View BVdb publication page



Antioxidant gene therapy against neuronal cell death.

Pharmacology & Therapeutics
Navarro-Yepes, Juliana J; Zavala-Flores, Laura L; Anandhan, Annadurai A; Wang, Fang F; Skotak, Maciej M; Chandra, Namas N; Li, Ming M; Pappa, Aglaia A; Martinez-Fong, Daniel D; Del Razo, Luz Maria LM; Quintanilla-Vega, Betzabet B; Franco, Rodrigo R
Publication Date: 2014-05

Variant appearance in text: SNCA: Y39C
PubMed Link: 24333264
Variant Present in the following documents:
  • Main text
View BVdb publication page



Animal models of Parkinson's disease: a gateway to therapeutics?

Neurotherapeutics : The Journal Of The American Society For Experimental Neurotherapeutics
Le, Weidong W; Sayana, Pavani P; Jankovic, Joseph J
Publication Date: 2014-01

Variant appearance in text: SNCA: Y39C
PubMed Link: 24158912
Variant Present in the following documents:
  • Main text
View BVdb publication page



α-Synuclein and neuronal cell death.

Molecular Neurobiology
Yasuda, Toru T; Nakata, Yasuto Y; Mochizuki, Hideki H
Publication Date: 2013-04

Variant appearance in text: SNCA: Y39C
PubMed Link: 22936307
Variant Present in the following documents:
  • Main text
View BVdb publication page



Animal models of the non-motor features of Parkinson's disease.

Neurobiology Of Disease
McDowell, Kimberly K; Chesselet, Marie-Françoise MF
Publication Date: 2012-06

Variant appearance in text: SNCA: Y39C
PubMed Link: 22236386
Variant Present in the following documents:
  • Main text
View BVdb publication page



Parkinson's disease mouse models in translational research.

Mammalian Genome : Official Journal Of The International Mammalian Genome Society
Antony, Paul M A PM; Diederich, Nico J NJ; Balling, Rudi R
Publication Date: 2011-08

Variant appearance in text: SNCA: Y39C
PubMed Link: 21559878
Variant Present in the following documents:
  • Main text
  • 335_2011_Article_9330.pdf
View BVdb publication page



Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze?

Neurotoxicity Research
Buchman, Vladimir L VL; Ninkina, Natalia N
Publication Date: 2008-12

Variant appearance in text: SNCA: Y39C
PubMed Link: 19073436
Variant Present in the following documents:
  • 12640_2009_Article_BF03033857.pdf
View BVdb publication page